ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 46

Alarmins S100A8/A9 Regulate Osteophyte Formation In Experimental Osteoarthritis With High Synovial Activation

Rik Schelbergen1, Arjen B. Blom1, Wouter de Munter1, Annet W. Sloetjes2, Thomas Vogl3, Johannes Roth4, Wim B. van den Berg5 and Peter L.E.M. van Lent1, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands, 3Institute of Immunology, University of Muenster, Muenster, Germany, 4Immunology, Institute of Immunology University of Muenster, Muenster, Germany, 5Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Mesenchymal stem cells, Mouse model, Osteoarthritis, osteophytosis and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Osteophytes are cartilage capped, bony outgrowths that limit joint movement and originate from the periosteum or from ligaments during osteoarthritis (OA). There is increasing belief that the synovium contributes to OA joint pathology since a large subset of OA patients shows synovial activation. As shown recently in our lab, alarmins S100A8 and S100A9 (major products of activated synovial macrophages) are involved in cartilage degradation and synovial activation during human and murine OA. In the current study, we explored the involvement of S100A8/A9 in osteophyte formation in experimental OA.

Methods: Experimental OA was elicited in C57Bl/6 (WT) mice and S100A9-/- mice (in which peripheral myeloid cells lack functional S100A8), either by intra-articular collagenase injection (CIOA), or by transsection of the medial anterior meniscotibial ligament (DMM). Osteophyte size was assessed by a blinded observer using image analysis software. Chondrogenesis was induced by bringing human fetal mesenchymal stem cells (hMSCs) in pellet or murine C3H10T1/2 in micromass culture and stimulating for 5 (hMSCs) or 21 days (C3H10T1/2) with BMP-2 and TGFβ1, with 1 or 5 µg/ml human or mouse recombinant S100A8. Proteoglycan content was quantified on SafO stained sections, expression of mRNA with RT-qPCR.

Results: Synovial activation, which is high in CIOA, was significantly reduced in S100A9-/- mice. Osteophyte size at day 42 of CIOA was dramatically reduced in the S100A9-/- compared to WT in the medial collateral ligament (92,5% reduction, Figure 1), but also significantly at the medial side of both tibia and femur (68,2% and 64,6% reduction) (n=10). One explanation for the reduced osteophyte size in S100A9-/- mice may be a direct effect of S100-proteins on chondrogenesis. To investigate this, we first stimulated murine C3H10T1/2 MSCs in micromass culture with 5 µg/ml S100A8 (in the presence of BMP-2 and TGFβ1) and found a marked increase in MMP3 and aggrecan mRNA as well as a strongly altered morphology, indicating increased remodeling. In line with that, stimulation of human MSCs in pellet culture with 1 or 5 µg/ml S100A8 (again together with BMP-2 and TGFβ1) strongly increased proteoglycan deposition as measured by redness in SafO staining (27% and 71% increase respectively). Finally, we determined osteophyte size in the DMM model, in which synovial involvement is very low. At day 56, we observed no significant differences in osteophyte size between the S100A9-/- and WT at the medial femur and tibia (105% and 136% of WT, n=8).

Conclusion: S100A8/S100A9 play a crucial role in osteophyte formation in an OA model that shows high synovial involvement, probably by stimulating chondrogenesis. Considering also the deleterious effect of S100A8/A9 on joint destruction in OA, targeting these alarmins during OA may be very promising.

 


Disclosure:

R. Schelbergen,
None;

A. B. Blom,
None;

W. de Munter,
None;

A. W. Sloetjes,
None;

T. Vogl,
None;

J. Roth,
None;

W. B. van den Berg,
None;

P. L. E. M. van Lent,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/alarmins-s100a8a9-regulate-osteophyte-formation-in-experimental-osteoarthritis-with-high-synovial-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology